Former President Donald Trump has boasted in recent months about "Right to Try," a law he signed in 2018. It’s aimed at boosting terminally ill patients’ access to potentially life-saving medications ...
today announced that the U.S. Foodand DrugAdministration (FDA) has issued a complete response letter (CRL), dated October 22, 2024, for the ketamine Abbreviated New Drug Application, which ...